VIENNA/ NEW YORK/ GENEVA/ ADDIS ABABA/ NAY PYI TAW, 26 June – Improved research and more precise data have revealed that the adverse health consequences of drug use are more severe and widespread than previously thought. Globally, some 35 million people are estimated to suffer from drug use disorders and who require treatment services, according to the latest World Drug Report, released today by the United Nations Office on Drugs and Crime (UNODC).
estimates for 2017 are the result of improved knowledge of the extent of drug
use from new surveys conducted in India and Nigeria, both among the ten most
populous countries in the world.
also estimates the number of opioid users at 53 million, up 56 per cent from
previous estimates , and that opioids are
responsible for two thirds of the 585,000 people who died as a result of drug
use in 2017. Globally, 11 million people injected drugs in 2017, of whom 1.4
million live with HIV and 5.6 million with hepatitis C.
findings of this year’s World Drug Report fill in and further complicate the
global picture of drug challenges, underscoring the need for broader
international cooperation to advance balanced and integrated health and
criminal justice responses to supply and demand,” said Yury Fedotov, UNODC
and complexity of World Drug Situation increasing
In 2017, an
estimated 271 million people, or 5,5 per cent of the global population aged
15-64, had used drugs in the previous year. While this is similar to the 2016
estimate, a longer-term view reveals that the number of people who use drugs is
now 30 per cent higher than it was in 2009. Although that increase was in part
due to a 10 per cent growth in the global population aged 15-64, data now shows
a higher prevalence of the use of opioids in Africa, Asia, Europe and North
America and the use of cannabis in North America, South America and Asia
compared with 2009.
global illicit manufacture of cocaine reached an all-time high of 1,976 tons in
2017, an increase of 25 per cent on the previous year. At the same time, the
global quantity of cocaine seized in 2017 rose by 13 per cent to 1,275 tons,
the largest quantity ever reported.
America’s synthetic opioid overdose crisis also reached new heights in 2017,
with more than 47,000 opioid overdose deaths recorded in the United States, an
increase of 13 per cent from the previous year, and 4,000 opioid-related deaths
in Canada, a 33 per cent increase from 2016.
its analogues remain the key problem of the synthetic opioid crisis in North
America, but West and Central and North Africa are experiencing a crisis of
another synthetic opioid, tramadol. Global seizures of tramadol jumped from
less than 10 kilograms in 2010 to almost 9 tons in 2013 and reached a record
high of 125 tons in 2017.
widely used drug globally continues to be cannabis, with an estimated 188
million people having used the drug in 2017*.
shows that an area where the international community has had a degree of
success is in addressing new psychoactive substances (NPS), evidenced by a
decline in the number of NPS identified and reported for the first time to
UNODC. NPS have not been taken up in the market to the extent feared a few
years ago, and the international community has reacted in a timely manner to
assess the harms caused by NPS and to schedule those that warranted
and treatment continue to fall short
treatment continue to fall short in many parts of the world, with only one in
seven people with drug use disorders receiving treatment each year.
particularly striking in prisons. This year’s Report provides in-depth analysis
of drug use and its adverse health consequences in prison settings, which
suggests that the prevalence of infectious diseases such as HIV, hepatitis C
and active tuberculosis, and related risks, are disproportionately higher among
prison populations than among the general population, in particular among those
who inject drugs in prison.
countries reported that they provided opioid substitution therapy in at least
one prison in 2017, while 46 countries reported not having such a treatment
option in prison settings. Needle-syringe programmes are far less available in
prison: 11 countries reported their availability in at least one prison, but
such programmes were confirmed as absent in 83 countries.
shows that effective treatment interventions based on scientific evidence and
in line with international human rights obligations are not as available or
accessible as they need to be, and national governments and the international
community need to step up interventions in order to address this gap.
The World Drug Report and further content is available here:
The 2019 World
Drug Report provides a global overview of the supply and demand of opiates,
cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances
(NPS), as well as their impact on health. It highlights, through improved
research and more precise data, that the adverse health consequences of drug
use are more widespread than previously thought.